|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 605.55 INR | +0.25% |
|
-3.27% | +38.10% |
Company Valuation: Coral Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 350.1 | 1,151 | 912.1 | 817.8 | 1,327 | 2,506 |
| Change | - | 228.83% | -20.78% | -10.34% | 62.25% | 88.85% |
| Enterprise Value (EV) 1 | 398.1 | 1,191 | 729.8 | 517.7 | 1,049 | 2,232 |
| Change | - | 199.05% | -38.7% | -29.07% | 102.64% | 112.77% |
| P/E | 4.91x | 8.49x | 10.1x | 12.7x | 8.4x | 10.4x |
| PBR | 0.3x | 0.84x | 0.58x | 0.53x | 0.75x | 1.25x |
| PEG | - | 0.1x | -0.3x | -0.4x | 0x | 0.2x |
| Capitalization / Revenue | 0.5x | 1.19x | 1.21x | 1.05x | 1.59x | 2.18x |
| EV / Revenue | 0.56x | 1.23x | 0.97x | 0.66x | 1.25x | 1.94x |
| EV / EBITDA | 6.98x | 7.33x | 8.51x | 12.2x | 6.33x | 8.39x |
| EV / EBIT | 10.7x | 8.34x | 11.1x | 25x | 7.18x | 9.07x |
| EV / FCF | -4.65x | -62.2x | -107x | 7.71x | -11.2x | -25.8x |
| FCF Yield | -21.5% | -1.61% | -0.93% | 13% | -8.94% | -3.88% |
| Dividend per Share 2 | - | - | - | - | 2 | 1.5 |
| Rate of return | - | - | - | - | 0.54% | 0.21% |
| EPS 2 | 19.96 | 37.94 | 25.32 | 18.04 | 44.19 | 67.61 |
| Distribution rate | - | - | - | - | 4.53% | 2.22% |
| Net sales 1 | 705.8 | 965.7 | 756.1 | 781.2 | 836.6 | 1,150 |
| EBITDA 1 | 57 | 162.5 | 85.74 | 42.45 | 165.8 | 265.9 |
| EBIT 1 | 37.12 | 142.8 | 65.97 | 20.73 | 146.1 | 246 |
| Net income 1 | 71.3 | 135.5 | 90.46 | 64.45 | 157.9 | 241.6 |
| Net Debt 1 | 48.01 | 39.3 | -182.3 | -300.1 | -277.9 | -273.9 |
| Reference price 2 | 98.00 | 322.25 | 255.30 | 228.90 | 371.40 | 701.40 |
| Nbr of stocks (in thousands) | 3,573 | 3,573 | 3,573 | 3,573 | 3,573 | 3,573 |
| Announcement Date | 8/20/20 | 9/1/21 | 9/6/22 | 7/18/23 | 9/5/24 | 9/3/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 22.72M | ||
| 35.49x | 12.89x | 26.26x | 0.56% | 1,082B | ||
| 28.11x | 6.46x | 17.57x | 2.03% | 633B | ||
| 32.2x | 7.69x | 15.73x | 2.65% | 461B | ||
| 18.15x | 4.51x | 11.08x | 2.94% | 338B | ||
| 24.06x | 5.03x | 14.1x | 1.73% | 299B | ||
| 22.19x | 5.69x | 13.74x | 2.76% | 291B | ||
| 14.43x | 5.37x | 11.03x | 3.47% | 222B | ||
| 24.39x | 6.45x | 11.36x | 2.7% | 202B | ||
| -46.87x | 5.66x | 31.47x | 2.47% | 163B | ||
| Average | 16.90x | 6.64x | 16.92x | 2.37% | 369.24B | |
| Weighted average by Cap. | 24.74x | 8.04x | 18.59x | 1.94% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CORALAB6 Stock
- Valuation Coral Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















